Lawsuit alleges pharma giants funded terror in Iraq

pharmafile | August 2, 2018 | News story | Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism 

The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that they gave to the Iraqi government would be used to fund terror attacks against American troops.

The families of dozens of troops who had been injured or killed during the Iraq war have filed a federal lawsuit against AstraZeneca, Johnson & Johnson, Roche, Pfizer and General Electric alleging that the companies had known that the supplies they had given to the Iraqi Health Ministry, in order to win contracts, would be used to fund terror operations.

The British based multinational AstraZeneca confirmed that inquiries had been made as it stated it had “received an inquiry from the U.S. Department of Justice in connection with an anti-corruption investigation relating to activities in Iraq.”

The lawsuit claims that the Iraqi Health Ministry sold the free supplies that were given to them on the black market in order to fund terror attacks against American forces. The health ministry, which at the time was under the control of the radical Shiite cleric Moktada al Sadr, leader of the Mahdi Army, is alleged to have “relied on corruption” in order to fund terror activities.

Sadr’s Mahdi army of 60,000 members has been blamed for thousands of killings. The organisation is accused of leading anti-Sunni death squads that frequently killed civilians during the civil war phase of the Iraq War. The lawsuit claims that the Iraqi Health Ministry employees played prominent roles in the Mahdi army and that the organisation was used to launch attacks, smuggle weapons and gather intelligence. The US government have claimed that Sadr’s army are linked to Iran.

Ryan Sparacino a lawyer acting on behalf of plaintiffs commented that: “As alleged by more than 300 Americans, Iranian-backed terrorists have used corruption at the Iraqi health ministry to help fund their terrorist operations in Iraq since at least 2004.”

However the defendants in the lawsuit have argued that the US government had encouraged them to win contracts with the Iraqi government. They noted in a statement that: “the United States expressly encouraged companies to sell and to donate to the ministry millions of dollars’ worth of medicines and medical supplies.”

Louis Goss

Related Content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence …

AstraZeneca’s phase 4 trial stopped early after reaching pre-specified criteria

AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after …


AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 …

Latest content